Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 9;23(2):2207-2224.
doi: 10.1007/s40200-024-01489-1. eCollection 2024 Dec.

Sex disparity in the burden of NCDs and its four main subgroups in Iran 1990-2019: a systematic analysis from the global burden of disease study 2019

Affiliations

Sex disparity in the burden of NCDs and its four main subgroups in Iran 1990-2019: a systematic analysis from the global burden of disease study 2019

Mahdie Fatollahzade et al. J Diabetes Metab Disord. .

Abstract

Objectives: The significant health differences between sexes in Iran in terms of burden of non-communicable diseases (NCDs) point to the urgency of developing policies. We aim to explore sex disparities in NCDs.

Methods: We used Global Burden of Disease 2019 study to compare estimates of incidence, prevalence, disability-adjusted life years (DALYs), years lived with disabilities (YLDs), years of life lost (YLLs), and deaths among sexes for NCDs, and their main subgroups; neoplasms, cardiovascular diseases (CVDs), chronic respiratory diseases (CRDs), diabetes mellitus (DM) during 1990-2019.

Results: In 2019, there were 62,476,274 (59517167.5, 65759931) incident NCDs in men and 78758640.6 (75222093.7, 82272935.8) in women. There were 7734064.3 (6744951.2, 8846192) DALYs in men and 7760484.2 (6496609, 9218299.9) in women. Fatal estimates (deaths and YLLs) of NCDs were higher for men, while non-fatal estimates (prevalence, YLDs) were higher for women. Men were superior in all burden indices of NCDs subgroups, except for all indices of DM and YLDs in CVDs. Compared to 1990-2010, the period 2010-2019 confirmed a marked stagnation in decline rates of burden indices, as well as an increase in incidence and prevalence which was more pronounced among men. Despite shrinking sex gaps in NCDs subgroups since 1990, sex gap in DM is widening in 2019.

Conclusions: There is a notable sex disparity in NCDs prevalence in Iran, which has become increasingly evident in DM burden. It will be imperative to continue monitoring sexual differences in NCDs burden to determine if disease rates between sexes continue to diverge in the future.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-024-01489-1.

Keywords: Diabetes; Global burden of Disease Study; Iran; Neoplasm; Non-communicable diseases; Sex.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors had no conflicts of interest.

Figures

Fig. 1
Fig. 1
Rate of change in age-standardized rate of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), prevalence, and incidence of non-communicable diseases among men and women in 1990–2010 and 2010–2019 in Iran
Fig. 2
Fig. 2
Time trend of age-standardized rate of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), prevalence, and incidence of non-communicable diseases by sex in from 1990 to 2019 in Iran
Fig. 3
Fig. 3
Rate of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), prevalence, and incidence of non-communicable disease by age and sex in 1990 and 2019 in Iran
Fig. 4
Fig. 4
Age-standardized rate of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), prevalence, and incidence of non-communicable disease by sociodemographic index (SDI) quintiles among both sexes in 1990 and 2019 in Iran

References

    1. Farzadfar F, Naghavi M, Sepanlou SG, Moghaddam SS, Dangel WJ, Weaver ND, et al. Health system performance in Iran: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2022;399(10335):1625–45. - PMC - PubMed
    1. Moazzeni SS, Ghafelehbashi H, Hasheminia M, Parizadeh D, Ghanbarian A, Azizi F, et al. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011. BMC Public Health. 2020;20:1–9. - PMC - PubMed
    1. Bayati M, Kiadaliri A. Contributions of avoidable mortality to the sex gap in life expectancy and life disparity in Iran. Archives Public Health. 2023;81(1):126. - PMC - PubMed
    1. Farzadfar F, Yousefi M, Jafari-Khounigh A, Khorrami Z, Haghdoost A, Shadmani FK. Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030. Sci Rep. 2024;14(1):8092. - PMC - PubMed
    1. Ramezankhani A, Azizi F, Momenan AA, Hadaegh F. Sex differences in cumulative exposure to metabolic risk factors before hypertension onset: the cohort of the tehran lipid and glucose study. J Am Heart Association. 2021;10(23):e021922. - PMC - PubMed

LinkOut - more resources